Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Elly Kourany-Lefoll"'
Autor:
Muhidin K Mahende, Eric Huber, Elly Kourany-Lefoll, Ali Ali, Brooke Hayward, Deon Bezuidenhout, Wilhelmina Bagchus, Abdunoor M Kabanywanyi
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 15, Iss 6, p e0007370 (2021)
BackgroundPraziquantel (PZQ) is currently the only recommended drug for infection and disease caused by the schistosome species that infects humans; however, the current tablet formulation is not suitable for pre-school age children mainly due to its
Externí odkaz:
https://doaj.org/article/8e1535fdaa314ef59361cd0f4087725f
Autor:
Wilhelmina Maria Bagchus, Deon Bezuidenhout, Eleanor Harrison‐Moench, Elly Kourany‐Lefoll, Peter Wolna, Oezkan Yalkinoglu
Publikováno v:
Clinical and Translational Science, Vol 12, Iss 1, Pp 66-76 (2019)
Orally dispersible tablet (ODT) formulations of levo praziquantel (L‐PZQ) and racemic PZQ (rac‐PZQ) are being developed to treat schistosomiasis in preschool‐aged children. Two crossover studies (N = 32 and 36, respectively) assessed the relati
Externí odkaz:
https://doaj.org/article/936d038baeca4aaf9835448040d0e918
Autor:
Leonie Hussaarts, Kim van der Weijde, Pierre Dome, Elly Kourany-Lefoll, Jutta Reinhard-Rupp, Remco de Vrueh, Pediatric Praziquantel Consortium
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 11, Iss 2, p e0005183 (2017)
Externí odkaz:
https://doaj.org/article/47ad14c1049145e2976f5a60e234b3d0
Autor:
Eliézer K N'Goran, Maurice R Odiere, Ronald Assandé Aka, Mamadou Ouattara, N A David Aka, Bernhards Ogutu, Fredrick Rawago, Wilhelmina M Bagchus, Matthias Bödding, Elly Kourany-Lefoll, Aliona Tappert, Xiaoyan Yin, Deon Bezuidenhout, Henk Badenhorst, Eric Huber, Benjamin Dälken, Okba Haj-Ali Saflo
Publikováno v:
The Lancet Infectious Diseases.
Autor:
Deon Bezuidenhout, Mamadou Ouattara, Elly Kourany-Lefoll, Eliézer K. N’Goran, Eric Huber, Brooke Hayward, Özkan Yalkinoglu, N. A. David Aka, Aliona Tappert, Xiaoyan Yin, Wilhelmina Bagchus
Publikováno v:
Frontiers in Tropical Diseases. 2
IntroductionTwo novel formulations of praziquantel (PZQ) and Levo-(L-)PZQ (arpraziquantel) have been developed for the treatment of schistosomiasis in preschool-age children and infants.MethodsThis open-label, dose-finding Phase 2 study assessed the
Autor:
Eric Huber, Deon Bezuidenhout, Xiaoyan Yin, Brooke Hayward, Özkan Yalkinoglu, Nana R. Diakité, Aliona Tappert, Fidèle K. Bassa, Elly Kourany-Lefoll, Eliézer K. N’Goran, Mamadou Ouattara, Wilhelmina Bagchus, Nad. Aka
Publikováno v:
Frontiers in Tropical Diseases. 2
IntroductionTraditionallySchistosoma mansoniinfection is diagnosed by the Kato-Katz method. Thick smears from each stool sample are prepared on slides and eggs are counted microscopically. Commercially available point-of-care circulating cathodic ant
Autor:
Deon Bezuidenhout, Ali Ali, Muhidin K. Mahende, Wilhelmina Bagchus, Abdunoor M. Kabanywanyi, Brooke Hayward, Eric Huber, Elly Kourany-Lefoll
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 15, Iss 6, p e0007370 (2021)
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases
Background Praziquantel (PZQ) is currently the only recommended drug for infection and disease caused by the schistosome species that infects humans; however, the current tablet formulation is not suitable for pre-school age children mainly due to it
Autor:
Eleanor Harrison-Moench, Peter Wolna, Oezkan Yalkinoglu, Wilhelmina Bagchus, Elly Kourany-Lefoll, Deon Bezuidenhout
Publikováno v:
Clinical and Translational Science, Vol 12, Iss 1, Pp 66-76 (2019)
Clinical and Translational Science
Clinical and Translational Science
Orally dispersible tablet (ODT) formulations of levo praziquantel (L‐PZQ) and racemic PZQ (rac‐PZQ) are being developed to treat schistosomiasis in preschool‐aged children. Two crossover studies (N = 32 and 36, respectively) assessed the relati
Autor:
Eliézer, N'Goran, N'da Angbeletchi, David Aka, Mamadou, Ouattara, Eric, Huber, Deon, Bezuidenhout, Elly, Kourany-Lefoll
Publikováno v:
Advances in parasitology. 103
The importance of implementing paediatric clinical trials for neglected tropical diseases (NTDs) in compliance with the Good Clinical Practices of the International Conference of Harmonisation (ICH-GCP) and other applicable regulatory and ethics guid
Autor:
Elly Kourany-Lefoll, Thomas Spangenberg, Kamala Tyagarajan, Claude Oeuvray, Beatrice Greco, Bettina Magsaam, Jim Mulry
Publikováno v:
BMJ Global Health. 2:A25.3-A26
Background Integrated health care approaches are the most effective ways to tackle infectious diseases such as malaria. Within its Global Health activities focusing on health issues of vulnerable populations within developing environments, Merck has